Goodwin Procter LLP
International law firm offering regulatory, litigation, transactional and technology-focused legal services across life sciences, healthcare, financial services and technology. Advises on market access and drug pricing compliance, IP and product litigation, corporate transactions, AI governance, data privacy and cross-border regulatory matters. Publishes educational webinars, trackers and interactive charts analyzing legal and market trends.
Industries
Nr. of Employees
Very Large (1000+)
Goodwin Procter LLP
Services
Legal advisory on market access, drug pricing programs, reporting and state/federal compliance for manufacturers, distributors and payors.
Advice on AI governance, IP, data use, privacy, cybersecurity, antitrust and contractual matters related to AI and software products.
Representation in government investigations, enforcement actions and litigation including health-care enforcement and False Claims Act defense.
Due diligence on regulatory, IP and compliance matters for M&A, private equity and capital markets transactions; drafting representations and warranties.
Advisory and contract drafting to align ICT provider relationships with DORA and UK critical third‑party requirements, gap assessments and assistance establishing EU oversight entities.
Production and dissemination of webinars, recorded videos, trackers and interactive charts that explain legal developments, market trends and regulatory issues.
Legal advisory on market access, drug pricing programs, reporting and state/federal compliance for manufacturers, distributors and payors.
Advice on AI governance, IP, data use, privacy, cybersecurity, antitrust and contractual matters related to AI and software products.
Representation in government investigations, enforcement actions and litigation including health-care enforcement and False Claims Act defense.
Due diligence on regulatory, IP and compliance matters for M&A, private equity and capital markets transactions; drafting representations and warranties.
Advisory and contract drafting to align ICT provider relationships with DORA and UK critical third‑party requirements, gap assessments and assistance establishing EU oversight entities.
Production and dissemination of webinars, recorded videos, trackers and interactive charts that explain legal developments, market trends and regulatory issues.
Expertise Areas
- Market access and drug pricing regulatory counsel
- Life sciences regulatory compliance and FDA readiness
- Biosimilars patent and regulatory strategy
- Intellectual property litigation and post-grant proceedings
Key Technologies
- AI governance frameworks and risk assessment
- Cloud services and ICT third‑party management
- Threat-led penetration testing
- Cybersecurity incident response and reporting
News & Updates
Recorded webinar addressing disclosures and discovery issues arising in biosimilars patent-dance processes.
Webinar providing an overview of players, products and regulatory/legal schemes in the China biosimilars market and comparisons with the U.S. market.
Symposium convening life-sciences, technology and investment leaders to discuss AI-enabled drug discovery and related regulatory considerations.
Webinar series addressing patent term strategy, FDA readiness, IP and regulatory issues for late-stage drug products.
Ongoing tracker and periodic issues summarizing PTAB, district-court and Federal Circuit developments in post-grant matters.
Collection of interactive charts and visualizations summarizing enforcement, M&A, securities litigation and other market trends relevant to clients.
Recorded webinar addressing disclosures and discovery issues arising in biosimilars patent-dance processes.
Webinar providing an overview of players, products and regulatory/legal schemes in the China biosimilars market and comparisons with the U.S. market.
Symposium convening life-sciences, technology and investment leaders to discuss AI-enabled drug discovery and related regulatory considerations.
Webinar series addressing patent term strategy, FDA readiness, IP and regulatory issues for late-stage drug products.
Ongoing tracker and periodic issues summarizing PTAB, district-court and Federal Circuit developments in post-grant matters.
Collection of interactive charts and visualizations summarizing enforcement, M&A, securities litigation and other market trends relevant to clients.